Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Image source: Getty Images

Dexus Industria REIT (ASX: DXI)

According to a note out of Bell Potter, its analysts have upgraded this industrial property company's shares to a buy rating with a $3.10 price target. It notes that Dexus Industria's FY 2025 result was slightly ahead of expectations. And while its dividend guidance for the year ahead was softer than expected, this has been driven by an asset sale. So, with its shares underperforming other REITs, the broker sees value on offer here for investors. Particularly given that there is strong sector tailwinds for industrial property evidenced in direct markets. The Dexus Industria share price is trading at $2.88 this afternoon.

Pro Medicus Ltd (ASX: PME)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating on this health imaging technology company's shares with an improved price target of $350.00. This follows the release of an impressive FY 2025 result which was ahead of the broker's expectations. It also notes that its sales pipeline and contract wins indicate that growth in FY 2026 is likely to be even better than forecast. As a result, it has boosted its earnings forecasts for the coming years and valuation accordingly. The Pro Medicus share price is fetching $311.84 at the time of writing.

Telstra Group Ltd (ASX: TLS)

Analysts at Macquarie have retained their outperform rating on this telco giant's shares with a trimmed price target of $5.04. According to the note, Telstra delivered a softer than expected mobile result in a noisy year. However, looking through the one-off impacts in FY 2025, it remains positive. It highlights rational MNO pricing and strong cost-out tailwinds, plus ICF earnings as drivers of growth. In fact, it expects mid single-digit cash earnings per share growth over the coming years. Another positive is that strong demand has been flagged in InfraCo and Intercity Fibre has kicked off, with additional routes to open in FY 2026. It expects this to help it achieve its FY 2030 goals. The Telstra share price is trading at $4.84 on Friday afternoon.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group and Telstra Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Xero and Northern Star shares

A leading expert forecasts ongoing headwinds for Xero and Northern Star shares. But why?

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Up 118%! Are PLS shares now a buy, hold or sell?

A leading expert provides his outlook for PLS' surging shares.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Broker Notes

Buy, hold, sell: ANZ Bank, Iress, and JB Hi-Fi shares

Here's what Morgans thinks of these shares following recent updates.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Is the CSL share price in the buy zone after the biotech giant's results?

Is the biotech giant a buy following its results release?

Read more »

ASX 200 bank share trading depicted by red buy and sell dice tumbling across a sheet of data in colourful graphics
Broker Notes

With $30 billion in FY26 income, should I buy CBA shares today?

A leading analyst digs into the outlook for CBA’s slipping shares.

Read more »

Woman and man calculating a dividend yield.
Broker Notes

Buy, hold, sell: REA, Northern Star Resources, Suncorp shares

Two experts share their views on three ASX 200 shares.

Read more »

Two female executives looking at a clipboard together.
Broker Notes

Buy, hold, sell: Centuria Industrial REIT, Endeavour, Wildcat Resources shares

Experts share their views on the lithium miner, hotels operator, and industrial ASX REIT.

Read more »

A group of five engineers wearing hard hats and some in high visibility vests raise their arms in happy celebration atop a building site with construction and equipment in the background.
Broker Notes

Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30%

A top wealth manager forecasts more than 30% returns from this ASX mining stock.

Read more »